These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33668382)

  • 1. A Robust Bioassay of the Human Bradykinin B
    Marceau F; Bachelard H
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33668382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Arg
    Bachelard H; Charest-Morin X; Marceau F
    Front Pharmacol; 2018; 9():273. PubMed ID: 29636689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.
    Charest-Morin X; Raghavan A; Charles ML; Kolodka T; Bouthillier J; Jean M; Robbins MS; Marceau F
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00119. PubMed ID: 26038695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B
    Charest-Morin X; Bachelard H; Jean M; Marceau F
    PeerJ; 2017; 5():e2911. PubMed ID: 28133580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor.
    Marceau F; Houle S; Bouthillier J; Said NB; Garratt PJ; Dziadulewicz EK
    Peptides; 2001 Sep; 22(9):1397-402. PubMed ID: 11514020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation.
    Marceau F; Bachelard H; Bouthillier J; Fortin JP; Morissette G; Bawolak MT; Charest-Morin X; Gera L
    Int Immunopharmacol; 2020 Feb; 82():106305. PubMed ID: 32106060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopeptidase-activated latent ligands of the histamine receptor-1.
    Gera L; Roy C; Charest-Morin X; Marceau F
    Int Immunopharmacol; 2013 Nov; 17(3):677-83. PubMed ID: 24016859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B
    Gera L; Charest-Morin X; Jean M; Bachelard H; Marceau F
    BMC Res Notes; 2016 Sep; 9(1):452. PubMed ID: 27670785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist.
    Savard M; Labonté J; Dubuc C; Neugebauer W; D'Orléans-Juste P; Gobeil F
    Biol Chem; 2013 Mar; 394(3):353-60. PubMed ID: 23362191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The isolated human umbilical vein as a bioassay for kinin-generating proteases: An in vitro model for therapeutic angioedema agents.
    Jean M; Raghavan A; Charles ML; Robbins MS; Wagner E; Rivard GÉ; Charest-Morin X; Marceau F
    Life Sci; 2016 Jun; 155():180-8. PubMed ID: 27165535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are noscapine and raloxifene ligands of the bradykinin B
    Bachelard H; Marceau F
    Int Immunopharmacol; 2022 Sep; 110():108984. PubMed ID: 35780642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue kallikrein actions at the rabbit natural or recombinant kinin B2 receptors.
    Houle S; Molinaro G; Adam A; Marceau F
    Hypertension; 2003 Mar; 41(3):611-7. PubMed ID: 12623967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B
    Jakwerth CA; Feuerherd M; Guerth FM; Oelsner M; Schellhammer L; Giglberger J; Pechtold L; Jerin C; Kugler L; Mogler C; Haller B; Erb A; Wollenberg B; Spinner CD; Buch T; Protzer U; Schmidt-Weber CB; Zissler UM; Chaker AM
    J Mol Med (Berl); 2022 Apr; 100(4):613-627. PubMed ID: 35247068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
    Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Lesage A; Gibson C; Marceau F; Ambrosi HD; Saupe J; Katzer W; Loenders B; Charest-Morin X; Knolle J
    Front Pharmacol; 2020; 11():916. PubMed ID: 32636746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional ligands of the bradykinin B
    Marceau F; Bawolak MT; Fortin JP; Morissette G; Roy C; Bachelard H; Gera L; Charest-Morin X
    Peptides; 2018 Jul; 105():37-50. PubMed ID: 29802875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase-activated B2 receptor agonists.
    Charest-Morin X; Roy C; Fortin EJ; Bouthillier J; Marceau F
    Front Pharmacol; 2014; 5():32. PubMed ID: 24639651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse.
    Moran CS; Rush CM; Dougan T; Jose RJ; Biros E; Norman PE; Gera L; Golledge J
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):898-907. PubMed ID: 26966276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.
    Desposito D; Chollet C; Taveau C; Descamps V; Alhenc-Gelas F; Roussel R; Bouby N; Waeckel L
    Clin Sci (Lond); 2016 Jan; 130(1):45-56. PubMed ID: 26443866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.